| 1 |
Pace Analytical Life Sciences, LLC v. Zydus Pharmaceuticals (USA) Inc. et al |
1:25-mc-00170 |
D.Del. |
|
|
|
|
| 2 |
Bayer Pharma AG et al v. Lupin Limited et al |
1:24-cv-00138 |
D.Del. |
|
|
|
|
| 3 |
Bayer Pharma AG et al v. Lupin Limited et al |
1:24-cv-00138 |
D.Del. |
|
|
|
|
| 4 |
Bayer Pharma AG et al v. Lupin Limited et al |
1:24-cv-00138 |
D.Del. |
|
|
|
|
| 5 |
Vertex Pharmaceuticals Incorporated v. Lupin Limited et al |
1:23-cv-00581 |
D.Del. |
|
|
|
|
| 6 |
THERAVANCE BIOPHARMA R&D IP, LLC et al v. EUGIA PHARMA SPECIALTIES LTD. et al |
1:23-cv-00926 |
D.N.J. |
|
- 8 Product company
- 12 IP subsidiary of product company
|
|
|
| 7 |
THERAVANCE BIOPHARMA R&D IP, LLC et al v. EUGIA PHARMA SPECIALTIES LTD. et al |
1:23-cv-00926 |
D.N.J. |
|
- 8 Product company
- 12 IP subsidiary of product company
|
|
|
| 8 |
THERAVANCE BIOPHARMA R&D IP, LLC et al v. EUGIA PHARMA SPECIALTIES LTD. et al |
1:23-cv-00926 |
D.N.J. |
|
- 8 Product company
- 12 IP subsidiary of product company
|
|
|
| 9 |
THERAVANCE BIOPHARMA R&D IP, LLC et al v. EUGIA PHARMA SPECIALTIES LTD. et al |
1:23-cv-00926 |
D.N.J. |
|
- 8 Product company
- 12 IP subsidiary of product company
|
|
|
| 10 |
THERAVANCE BIOPHARMA R&D IP, LLC et al v. EUGIA PHARMA SPECIALTIES LTD. et al |
1:23-cv-00926 |
D.N.J. |
|
- 8 Product company
- 12 IP subsidiary of product company
|
|
|
| 11 |
MERCK SHARP & DOHME LLC v. LUPIN LTD. et al |
2:23-cv-00094 |
D.N.J. |
|
|
|
|
| 12 |
Vifor Fresenius Medical Care Renal Pharma Ltd. et al v. Lupin Atlantis Holdings SA et al |
1:20-cv-00697 |
D.Del. |
|
|
|
|
| 13 |
Vifor Fresenius Medical Care Renal Pharma Ltd. et al v. Lupin Atlantis Holdings SA et al |
1:20-cv-00697 |
D.Del. |
|
|
|
|
| 14 |
Boehringer Ingelheim Pharmaceuticals Inc. et al v. Mankind Pharma Ltd. et al |
1:18-cv-01689 |
D.Del. |
|
|
|
|
| 15 |
Boehringer Ingelheim Pharmaceuticals Inc. et al v. Mankind Pharma Ltd. et al |
1:18-cv-01689 |
D.Del. |
|
|
|
|
| 16 |
Boehringer Ingelheim Pharmaceuticals Inc. et al v. Mankind Pharma Ltd. et al |
1:18-cv-01689 |
D.Del. |
|
|
|
|
| 17 |
Anacor Pharmaceuticals, Inc. v. Lupin Limited et al |
1:18-cv-01606 |
D.Del. |
|
|
|
|
| 18 |
SUN PHARMA GLOBAL FZE et al v. LUPIN LIMITED et al |
3:18-cv-02213 |
D.N.J. |
|
|
|
|
| 19 |
SUN PHARMA GLOBAL FZE et al v. LUPIN LIMITED et al |
3:18-cv-02213 |
D.N.J. |
|
|
|
|
| 20 |
HORIZON PHARMA, INC., ET AL. V. DR. REDDY'S LABORATORIES, INC., ET AL. |
2:17-cv-11635 |
D.N.J. |
|
|
|
|
| 21 |
HORIZON PHARMA, INC., ET AL. V. DR. REDDY'S LABORATORIES, INC., ET AL. |
2:17-cv-11635 |
D.N.J. |
|
|
|
|
| 22 |
ViiV Healthcare Company et al v. Lupin Limited et al |
1:17-cv-01576 |
D.Del. |
|
|
|
|
| 23 |
ViiV Healthcare Company et al v. Lupin Limited et al |
1:17-cv-01576 |
D.Del. |
|
|
|
|
| 24 |
ViiV Healthcare Company et al v. Lupin Limited et al |
1:17-cv-01576 |
D.Del. |
|
|
|
|
| 25 |
HORIZON THERAPEUTICS, LLC v. LUPIN LTD. et al |
2:17-cv-05900 |
D.N.J. |
|
|
|
|
| 26 |
Bayer Intellectual Property GMBH et al v. Taro Pharmaceutical Industries Ltd. et al |
1:17-cv-00462 |
D.Del. |
|
- 12 IP subsidiary of product company
- 8 Product company
|
|
|
| 27 |
Bayer Intellectual Property GMBH et al v. Taro Pharmaceutical Industries Ltd. et al |
1:17-cv-00462 |
D.Del. |
|
- 12 IP subsidiary of product company
- 8 Product company
|
|
|
| 28 |
Bayer Intellectual Property GMBH et al v. Taro Pharmaceutical Industries Ltd. et al |
1:17-cv-00462 |
D.Del. |
|
- 12 IP subsidiary of product company
- 8 Product company
|
|
|
| 29 |
HORIZON THERAPEUTICS, LLC v. LUPIN LTD. et al |
1:16-cv-04438 |
D.N.J. |
|
|
|
|
| 30 |
HORIZON THERAPEUTICS, LLC v. LUPIN LTD. et al |
1:16-cv-04438 |
D.N.J. |
|
|
|
|
| 31 |
Shire Development LLC et al v. Lupin Limited et al |
1:16-cv-00612 |
D.Md. |
|
- 8 Product company
- 12 IP subsidiary of product company
|
|
|
| 32 |
Shire Development LLC et al v. Lupin Limited et al |
1:16-cv-00612 |
D.Md. |
|
- 8 Product company
- 12 IP subsidiary of product company
|
|
|
| 33 |
Shire Development LLC et al v. Lupin Limited et al |
1:16-cv-00612 |
D.Md. |
|
- 8 Product company
- 12 IP subsidiary of product company
|
|
|
| 34 |
Shire Development LLC et al v. Lupin Limited et al |
1:16-cv-00612 |
D.Md. |
|
- 8 Product company
- 12 IP subsidiary of product company
|
|
|
| 35 |
Alcon Research, Ltd. v. Watson Laboratories, Inc., et al., |
1:15-cv-01159 |
D.Del. |
|
|
|
|
| 36 |
Vanda Pharmaceuticals Inc. v. Lupin Limited et al |
1:15-cv-01073 |
D.Del. |
|
|
|
|
| 37 |
Unimed Pharmaceuticals LLC et al v. Lupin Atlantis Holdings SA et al |
1:15-cv-00904 |
D.Del. |
|
|
|
|
| 38 |
Unimed Pharmaceuticals LLC et al v. Lupin Atlantis Holdings SA et al |
1:15-cv-00904 |
D.Del. |
|
|
|
|
| 39 |
Unimed Pharmaceuticals LLC et al v. Lupin Atlantis Holdings SA et al |
1:15-cv-00904 |
D.Del. |
|
|
|
|
| 40 |
HORIZON PHARMA IRELAND LIMITED et al v. LUPIN LTD. et al |
1:15-cv-06935 |
D.N.J. |
|
- 12 IP subsidiary of product company
- 8 Product company
|
|
|
| 41 |
HORIZON PHARMA IRELAND LIMITED et al v. LUPIN LTD. et al |
1:15-cv-06935 |
D.N.J. |
|
- 12 IP subsidiary of product company
- 8 Product company
|
|
|
| 42 |
HORIZON PHARMA IRELAND LIMITED et al v. LUPIN LTD. et al |
1:15-cv-06935 |
D.N.J. |
|
- 12 IP subsidiary of product company
- 8 Product company
|
|
|
| 43 |
ASTRAZENECA AB et al v. LUPIN LTD. et al |
3:15-cv-06092 |
D.N.J. |
|
|
|
|
| 44 |
ASTRAZENECA AB et al v. LUPIN LTD. et al |
3:15-cv-06092 |
D.N.J. |
|
|
|
|
| 45 |
ASTRAZENECA AB et al v. LUPIN LTD. et al |
3:15-cv-06092 |
D.N.J. |
|
|
|
|
| 46 |
ASTRAZENECA AB et al v. LUPIN LTD. et al |
3:15-cv-06092 |
D.N.J. |
|
|
|
|
| 47 |
ASTRAZENECA AB et al v. LUPIN LTD. et al |
3:15-cv-06092 |
D.N.J. |
|
|
|
|
| 48 |
Eli Lilly and Company et al v. Lupin Pharmaceuticals, Inc. et al |
1:15-cv-00877 |
E.D.Va. |
|
|
|
|
| 49 |
Eli Lilly and Company et al v. Lupin Pharmaceuticals, Inc. et al |
1:15-cv-00877 |
E.D.Va. |
|
|
|
|
| 50 |
Eli Lilly and Company et al v. Lupin Pharmaceuticals, Inc. et al |
1:15-cv-00877 |
E.D.Va. |
|
|
|
|